GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $949,000 | -46.2% | 32,240 | -20.4% | 0.10% | -56.8% |
| Q2 2022 | $1,763,000 | -0.1% | 40,502 | 0.0% | 0.23% | +30.0% |
| Q1 2022 | $1,764,000 | -1.5% | 40,502 | -0.3% | 0.18% | +23.3% |
| Q4 2021 | $1,791,000 | +15.4% | 40,613 | 0.0% | 0.15% | +13.2% |
| Q3 2021 | $1,552,000 | -2.7% | 40,613 | +1.4% | 0.13% | -5.1% |
| Q2 2021 | $1,595,000 | +11.6% | 40,052 | 0.0% | 0.14% | +19.3% |
| Q1 2021 | $1,429,000 | -3.1% | 40,052 | 0.0% | 0.11% | -10.9% |
| Q4 2020 | $1,474,000 | -3.9% | 40,052 | -1.7% | 0.13% | -53.5% |
| Q3 2020 | $1,534,000 | -7.7% | 40,752 | 0.0% | 0.28% | -13.5% |
| Q2 2020 | $1,662,000 | +2.6% | 40,752 | -4.7% | 0.32% | -8.1% |
| Q1 2020 | $1,620,000 | -20.9% | 42,752 | -1.8% | 0.35% | -16.0% |
| Q4 2019 | $2,047,000 | +10.1% | 43,552 | 0.0% | 0.41% | +13.5% |
| Q3 2019 | $1,859,000 | +8.1% | 43,552 | +1.3% | 0.36% | +22.6% |
| Q2 2019 | $1,720,000 | -3.1% | 42,980 | +1.2% | 0.30% | -5.7% |
| Q1 2019 | $1,775,000 | +9.4% | 42,480 | +0.1% | 0.31% | -2.8% |
| Q4 2018 | $1,622,000 | -7.0% | 42,452 | -2.3% | 0.32% | +6.2% |
| Q3 2018 | $1,745,000 | -2.2% | 43,452 | -1.8% | 0.30% | -3.8% |
| Q2 2018 | $1,784,000 | +3.2% | 44,252 | 0.0% | 0.32% | +16.2% |
| Q1 2018 | $1,729,000 | +11.7% | 44,252 | +1.4% | 0.27% | +5.0% |
| Q4 2017 | $1,548,000 | -14.6% | 43,652 | -2.2% | 0.26% | -17.0% |
| Q3 2017 | $1,813,000 | -14.7% | 44,652 | -9.4% | 0.31% | -12.4% |
| Q2 2017 | $2,126,000 | +0.9% | 49,300 | -1.4% | 0.36% | +26.7% |
| Q1 2017 | $2,108,000 | +8.6% | 50,000 | -0.8% | 0.28% | +14.7% |
| Q4 2016 | $1,941,000 | -13.0% | 50,400 | -2.5% | 0.24% | -38.0% |
| Q3 2016 | $2,230,000 | -80.8% | 51,700 | -50.4% | 0.40% | -70.2% |
| Q2 2016 | $11,619,000 | +449.9% | 104,200 | +100.0% | 1.32% | +142.0% |
| Q1 2016 | $2,113,000 | -22.7% | 52,100 | -23.1% | 0.55% | -18.4% |
| Q4 2015 | $2,734,000 | +5.2% | 67,746 | +0.2% | 0.67% | +6.5% |
| Q3 2015 | $2,599,000 | -53.7% | 67,596 | -49.8% | 0.63% | -12.2% |
| Q2 2015 | $5,610,000 | +1.1% | 134,700 | +3.8% | 0.72% | +95.1% |
| Q4 2014 | $5,548,000 | -6.5% | 129,800 | +0.6% | 0.37% | -8.2% |
| Q3 2014 | $5,932,000 | -14.1% | 129,050 | 0.0% | 0.40% | -12.7% |
| Q2 2014 | $6,902,000 | +0.1% | 129,050 | 0.0% | 0.46% | -4.4% |
| Q1 2014 | $6,895,000 | +0.1% | 129,050 | 0.0% | 0.48% | -31.2% |
| Q4 2013 | $6,890,000 | +6.4% | 129,050 | 0.0% | 0.70% | +50.0% |
| Q3 2013 | $6,474,000 | +0.2% | 129,050 | +0.2% | 0.46% | -2.9% |
| Q2 2013 | $6,463,000 | – | 128,800 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |